Sumicad, Merlyn A.

HRN: 26-43-31  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/28/2024
CEFUROXIME 1.5GM (VIAL)
12/28/2024
12/28/2024
IV
1.5 Grams
PTOR
Prophylaxis For OR
Waiting Final Action 
12/28/2024
CEFUROXIME 1.5GM (VIAL)
12/28/2024
12/31/2024
IV
1.5gm 3 Doses
Q8
Post CS
Waiting Final Action 
12/28/2024
CEFUROXIME 500MG (TAB)
12/28/2024
01/03/2025
PO
500mg
BID
Post Cs
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: